MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration SRAS - Exploration (Accueil)

Index « MeshFr.i » - entrée « Lopinavir »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Londres < Lopinavir < Lopéramide  Facettes :

List of bibliographic references indexed by Lopinavir

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000035 (2020) H. Li [République populaire de Chine] ; Y M Wang [République populaire de Chine] ; J Y Xu [République populaire de Chine] ; B. Cao [République populaire de Chine][Potential antiviral therapeutics for 2019 Novel Coronavirus].
001088 (2016) Yin Mo [Singapour] ; Dale Fisher [Singapour]A review of treatment modalities for Middle East Respiratory Syndrome
001783 (2014) Adriaan H. De Wilde [Pays-Bas] ; Dirk Jochmans [Belgique] ; Clara C. Posthuma [Pays-Bas] ; Jessika C. Zevenhoven-Dobbe [Pays-Bas] ; Stefan Van Nieuwkoop [Pays-Bas] ; Theo M. Bestebroer [Pays-Bas] ; Bernadette G. Van Den Hoogen [Pays-Bas] ; Johan Neyts [Belgique] ; Eric J. Snijder [Pays-Bas]Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
001828 (2013) Hisham Momattin [Arabie saoudite] ; Khurram Mohammed [Arabie saoudite] ; Alimuddin Zumla [Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] ; Jaffar A. Al-Tawfiq [États-Unis]Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
002004 (2011) V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
002005 (2011) V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
003071 (2008) Veena Nukoolkarn [Thaïlande] ; Vannajan Sanghiran Lee ; Maturos Malaisree ; Ornjira Aruksakulwong ; Supot HannongbuaMolecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors.
003637 (2007) Dessmon Y H. Tai [Singapour]Pharmacologic treatment of SARS: current knowledge and recommendations.
003C26 (2006) Yazdan Yazdanpanah ; Benoît Guéry[Antiretroviral drugs in severe acute respiratory syndrome].
003C98 (2006) Rolf Hilgenfeld [Allemagne] ; Ksenia PumporSometimes intermediates. Do the job!
005478 (2004) David S C. Hui [Hong Kong] ; Gary W K. WongAdvancements in the battle against severe acute respiratory syndrome.
005583 (2004) Xiao Ping Chen ; Yunzhen Cao [République populaire de Chine, États-Unis]Consideration of Highly Active Antiretroviral Therapy in the Prevention and Treatment of Severe Acute Respiratory Syndrome

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Lopinavir" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Lopinavir" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Lopinavir
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021